Viewing data from:

TRIFLUOPERAZINE HYDROCHLORIDE

ANDA

TRIFLUOPERAZINE HYDROCHLORIDE | A040209 | MYLAN PHARMACEUTICALS INC

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 8 NDCs

Highest NADAC/Unit

$1.24

per ea

Lowest NADAC/Unit

$0.4047

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51079057520TRIFLUOPERAZINE 10 MG TABLET	$1.24	EA	Generic	—	2026-10-21
00378241001TRIFLUOPERAZINE 10 MG TABLET	$1.24	EA	Generic	—	2026-10-21
51079057420TRIFLUOPERAZINE 5 MG TABLET	$0.7562	EA	Generic	—	2026-10-21
00378240501TRIFLUOPERAZINE 5 MG TABLET	$0.7562	EA	Generic	—	2026-10-21
51079057320TRIFLUOPERAZINE 2 MG TABLET	$0.5353	EA	Generic	—	2026-10-21
00378240201TRIFLUOPERAZINE 2 MG TABLET	$0.5353	EA	Generic	—	2026-10-21
00378240101TRIFLUOPERAZINE 1 MG TABLET	$0.4047	EA	Generic	—	2026-10-21
51079057220TRIFLUOPERAZINE 1 MG TABLET	$0.4047	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain1 active DMF3 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

TRIFARMA SPATRIFLUOPERAZINE HYDROCHLORIDE

DMF 28531977

IRISH FINE CHEMICALS LTDInactiveTRIFLUOPERAZINE

DMF 35151979

SMITH KLINE AND FRENCH LABORATORIESInactiveTRIFLUOPERAZINE HYDROCHLORIDE

DMF 47881983

ORCHIMIE SA (PRODUITS CHIMIQUES ET BIOCHIMIQUES)InactiveTRIFLUOPERAZINE

DMF 56991985

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#001 — EQ 1MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jul 7, 1997

No patent or exclusivity listings for this strength.

#002 — EQ 2MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 7, 1997

#003 — EQ 5MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 7, 1997

#004 — EQ 10MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jul 7, 1997